均瑶健康
(605388)
| 流通市值：45.52亿 | | | 总市值：45.52亿 |
| 流通股本：6.00亿 | | | 总股本：6.00亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 766,343,268.48 | 401,482,952.19 | 1,458,166,483.96 | 1,176,808,904.85 |
| 营业收入 | 766,343,268.48 | 401,482,952.19 | 1,458,166,483.96 | 1,176,808,904.85 |
| 二、营业总成本 | 772,573,006.06 | 391,483,113.73 | 1,429,428,073.5 | 1,126,480,653.88 |
| 营业成本 | 516,907,131.48 | 269,221,459.28 | 1,016,267,490.82 | 825,951,535.95 |
| 税金及附加 | 5,384,076.46 | 2,494,006.54 | 9,573,016.5 | 7,698,733.86 |
| 销售费用 | 161,485,037.34 | 75,040,972.82 | 244,604,493.42 | 168,176,285.41 |
| 管理费用 | 68,534,117.01 | 34,413,299 | 141,947,745.81 | 101,885,171.52 |
| 研发费用 | 19,819,312.92 | 10,076,572.33 | 34,642,214.07 | 23,749,319.78 |
| 财务费用 | 443,330.85 | 236,803.76 | -17,606,887.12 | -980,392.64 |
| 其中:利息费用 | 363,296.38 | 186,347.42 | 590,542.93 | 1,048,499.73 |
| 其中:利息收入 | 284,329.29 | 136,791.42 | 19,053,487.72 | 2,261,864.29 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 1,940,666.67 | -2,970,166.68 | 3,845,833.35 | 1,659,152.24 |
| 加:投资收益 | 528,933.77 | 4,374,767.12 | 5,835,444.86 | 5,835,444.86 |
| 资产处置收益 | 106,538.42 | 106,538.42 | 5,130,816.78 | 5,504,216.36 |
| 资产减值损失(新) | -1,367,525.76 | - | -49,196,909.35 | - |
| 信用减值损失(新) | 2,618,827.75 | -992,639.17 | -36,595,837.49 | -10,448,338.11 |
| 其他收益 | 5,503,214.22 | 2,774,472.62 | 12,729,087.24 | 12,101,768.54 |
| 四、营业利润 | 3,100,917.49 | 13,292,810.77 | -29,513,154.15 | 64,980,494.86 |
| 加:营业外收入 | 682,683.05 | 362,191.6 | 2,224,320.01 | 1,697,593.54 |
| 减:营业外支出 | 1,262,469.28 | 573,013.89 | 4,286,826.05 | 3,656,066.17 |
| 五、利润总额 | 2,521,131.26 | 13,081,988.48 | -31,575,660.19 | 63,022,022.23 |
| 减:所得税费用 | -354,257.03 | 3,459,508.8 | 1,861,218.49 | 15,982,664.15 |
| 六、净利润 | 2,875,388.29 | 9,622,479.68 | -33,436,878.68 | 47,039,358.08 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 2,875,388.29 | 9,622,479.68 | -33,436,878.68 | 47,039,358.08 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 7,466,072.75 | 10,907,104.58 | -29,116,350.88 | 49,421,033.21 |
| 少数股东损益 | -4,590,684.46 | -1,284,624.9 | -4,320,527.8 | -2,381,675.13 |
| 扣除非经常损益后的净利润 | 1,661,215.13 | 7,029,713.48 | -57,997,852.48 | 34,865,514.52 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.01 | 0.02 | -0.05 | 0.08 |
| (二)稀释每股收益 | 0.01 | 0.02 | -0.05 | 0.08 |
| 九、综合收益总额 | 2,875,388.29 | 9,622,479.68 | -33,436,878.68 | 47,039,358.08 |
| 归属于母公司股东的综合收益总额 | 7,466,072.75 | 10,907,104.58 | -29,116,350.88 | 49,421,033.21 |
| 归属于少数股东的综合收益总额 | -4,590,684.46 | -1,284,624.9 | -4,320,527.8 | -2,381,675.13 |
| 公告日期 | 2025-08-26 | 2025-04-30 | 2025-04-30 | 2024-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |